Related Experiment Video
Updated: Mar 7, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Vancomycin-induced Immune Hemolytic Anemia - A Case Report and Literature Review
Yilin Song1,2, Meher Ali1, Rukhsar Shaikh3
1Department of Internal Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, MD, USA.
Abstract:
Drug-induced immune hemolytic anemia (DIIHA) is a rare complication of drug treatment. The clinical presentation involves rapid dropping of hemoglobin secondary to hemolysis leading to potentially fatal consequences. Over 100 drugs have been reported to cause DIIHA, most commonly cephalosporins. Here, we present a case of vancomycin-induced immune hemolytic anemia. The diagnosis was challenging due to the limited reports of hemolytic anemia induced by vancomycin in the setting of multiple antibiotic administration history. Hemolysis improved after vancomycin cessation and diagnosis was made with positive serological confirmation. Literature review was performed with four reported cases of vancomycin-induced immune hemolytic anemia identified and summarized. Our goal is to promote awareness of vancomycin as an uncommon cause of DIIHA for better management in clinical practice.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Drug Toxicity: Allergic Reactions
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Risk factors

